ContraFect Corporation
USD0.05
-0.02 (-27.95%)
CEO
Michael Messinger CPA
IPO Date
2014-09-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.06
Prev. Close
$0.07
Day Low
$0.05
Day High
$0.06
52W Low
$0.03
52W High
$9.62
Volume
0.91M
| 42,000 |
| $3.35 |
| 18 May 2022 | Aklog Lishan | director: | A-Award | Acquired | 42,000 | $3.35 |
| 18 May 2022 | BARER SOL J | director: | A-Award | Acquired | 42,000 | $3.35 |
| 18 May 2022 | OTTO MICHAEL J. | director: | A-Award | Acquired | 42,000 | $3.35 |
| 18 May 2022 | Barlow Jane F | director: | A-Award | Acquired | 42,000 | $3.35 |
| 18 May 2022 | Sucoff Cary | director: | A-Award | Acquired | 42,000 | $3.35 |
| 18 May 2022 | GILMAN STEVEN C | director: | A-Award | Acquired | 42,000 | $3.35 |
| 17 Feb 2022 | Messinger Michael | Chief Financial Officer | A-Award | Acquired | 165,000 | $3.33 |
| 17 Feb 2022 | Pomerantz Roger | director, officer: Chief Executive Officer | A-Award | Acquired | 500,000 | $3.33 |